FRIDAY, Jan. 26, 2024 (HealthDay News) — Women in poorer areas of the United States have experienced a dramatic increase in advanced cervical cancer, a new study shows. Late-stage cervical cancer cases and deaths have gone up in U.S. counties with an average household income of between $19,330 and $38,820,Continue Reading
FRIDAY, Jan. 26, 2024 (HealthDay News) — While largely eliminated in more affluent nations, typhoid remains a deadly scourge in developing countries, killing more than 110,000 children every year. Children in endemic areas — mainly sub-Saharan Africa and southeast Asia — have new reason to hope, however, with the adventContinue Reading
THURSDAY, Jan. 25, 2024 (HealthDay News) — Reiterating a warning first issued in November, the U.S. Food and Drug Administration is urging Americans to stay away from supplements containing tianeptine, known on the street as “gas station heroin.” The supplements, sold under the brand name Neptune’s Fix online and atContinue Reading
WEDNESDAY, Jan. 24, 2024 (Healthday News) — The U.S. Food and Drug Administration has told drugmakers to add a boxed warning to a type of cancer treatment called CAR-T therapy, saying the treatment itself may sometimes cause a secondary cancer. Still, FDA spokesperson Carly Kempler told NBC News that, despiteContinue Reading
FRIDAY, Jan. 19, 2024 (HealthDay News) — People coming off antidepressants often struggle with emotional and social turmoil, especially if they quit their meds cold turkey, a new study reports. Challenges reported by patients quitting antidepressants included feeling overwhelmed by their emotions, finding social situations less enjoyable, and feeling detachedContinue Reading
THURSDAY, Jan. 18, 2024 (HealthDay News) — Fetal exposure to opioids may change a baby’s immune system, triggering a rise in risks for eczema and asthma through early childhood, new research shows. Children born to women who used opioids during pregnancy had much higher rates of eczema, as well asContinue Reading
TUESDAY, Jan. 16, 2024 (HealthDay News) — Vaccination can protect young people — particularly teenagers– against long COVID, a new study finds. Records of more than 1 million U.S. kids showed that the COVID jab can effectively shield kids from long-term health problems related to the infection, according to findingsContinue Reading
TUESDAY, Jan. 16, 2024 (HealthDay News) — There’s no link at all between weed use and a person’s use of illicit opioids, one way or the other, a new review concludes. Cannabis isn’t a gateway drug that can spark a person’s desire to try narcotics, results show. On the otherContinue Reading
MONDAY, Jan. 15, 2024 (HealthDay News) — Scientists from the U.S. Food and Drug Administration conclude in newly released documents that marijuana has less potential for abuse than other drugs with the same restrictions and it should be reclassified as a less dangerous drug. Not only that, the review foundContinue Reading
FRIDAY, Jan. 12, 2024 (HealthDay News) — A universal coronavirus vaccine could have saved millions of lives and billions of dollars if one had been available prior to the pandemic, a new study argues. Further, a universal vaccine — one that targets parts of the virus common to all coronavirusesContinue Reading
FRIDAY, Jan. 12, 2024 (HealthDay News) — Drugs like Wegovy and Ozempic, which have become a wildly popular way to lose weight or battle diabetes, show no link to suicidal thoughts or actions, the U.S. Food and Drug Administration said Thursday. “Our preliminary evaluation has not found evidence that useContinue Reading
FRIDAY, Jan. 12, 2024 (HealthDay News) — Sickle cell disease is one of many chronic health conditions that dramatically increases the risk of hospitalization and death in people infected by COVID-19. Unfortunately, folks with sickle cell disease are much less likely to have received the best protection available to themContinue Reading
THURSDAY, Jan. 11, 2024 (HealthDay News) — U.S. doctors are prescribing antifungal creams to patients with skin complaints at rates so high they could be contributing to the rise of drug-resistant infections, new research shows. These are “severe antimicrobial-resistant superficial fungal infections, which have recently been detected in the UnitedContinue Reading
THURSDAY, Jan. 11, 2024 (HealthDay News) — Amid an ongoing shortage of the first-line treatment for syphilis in the United States, the U.S. Food and Drug Administration will allow the importation of a different syphilis drug from a French drugmaker. In a letter from Laboratoires Delbert, the Paris-based company said it’sContinue Reading